Windlas Financial Statements From 2010 to 2025

Stocks . India . 
Stock . Windlas Biotech Limited
WINDLAS Stock   820.65  10.25  1.23%   
Windlas Biotech's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Windlas Biotech's valuation are provided below:
Gross Profit
3.1 B
Profit Margin
0.0811
Market Capitalization
17.4 B
Enterprise Value Revenue
1.817
Revenue
8.3 B
There are over eighty-two available fundamental gauges for Windlas Biotech, which can be analyzed over time and compared to other ratios. All traders should confirm Windlas Biotech's prevalent fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction.

Windlas Biotech Total Revenue

5.19 Billion

Check Windlas Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Windlas Biotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 159.7 M, Interest Expense of 22.3 M or Selling General Administrative of 30.2 M, as well as many indicators such as . Windlas financial statements analysis is a perfect complement when working with Windlas Biotech Valuation or Volatility modules.
  
This module can also supplement various Windlas Biotech Technical models . Check out the analysis of Windlas Biotech Correlation against competitors.

Windlas Biotech Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets5 B7.6 B3.8 B
Slightly volatile
Short and Long Term Debt Total198.4 M326 M387.7 M
Slightly volatile
Other Current Liabilities280.1 M518.6 M210 M
Slightly volatile
Total Current Liabilities1.5 B2.5 B1.4 B
Pretty Stable
Total Stockholder Equity3.4 B5.1 B2.3 B
Slightly volatile
Other Liabilities17.8 M20.7 M17.1 M
Pretty Stable
Net Tangible Assets2.4 B4.5 B1.9 B
Slightly volatile
Property Plant And Equipment Net1.3 B2.2 B1.1 B
Slightly volatile
Retained Earnings1.6 B2.7 B979.7 M
Slightly volatile
Accounts Payable983.6 M1.7 B878.8 M
Slightly volatile
Cash4 M4.2 M71.7 M
Slightly volatile
Non Current Assets Total1.8 B2.4 B1.6 B
Slightly volatile
Non Currrent Assets Other50.8 M53.5 M65.5 M
Slightly volatile
Other Assets74.3 M87.4 M70 M
Slightly volatile
Cash And Short Term Investments1.3 B2.4 B779.6 M
Slightly volatile
Net Receivables1.1 B1.7 B862.7 M
Slightly volatile
Common Stock Shares Outstanding21.8 M21.1 M18.5 M
Slightly volatile
Short Term Investments2.5 B2.4 B787.2 M
Slightly volatile
Liabilities And Stockholders Equity5 B7.6 B3.8 B
Slightly volatile
Non Current Liabilities Total54.7 M52.4 M132.8 M
Slightly volatile
Inventory580.3 M813.8 M453.9 M
Slightly volatile
Other Current Assets249.4 M365.9 M181.8 M
Slightly volatile
Other Stockholder Equity1.6 B2.2 B1.2 B
Slightly volatile
Total Liabilities1.6 B2.5 B1.5 B
Very volatile
Total Current Assets3.2 B5.3 B2.3 B
Slightly volatile
Accumulated Other Comprehensive Income123.8 M218.2 M71.9 M
Slightly volatile
Short Term Debt159.6 M303.5 M273.2 M
Slightly volatile
Intangible Assets60.6 M67.8 M240.6 M
Slightly volatile
Common Stock92.2 M104.8 M72.1 M
Slightly volatile
Property Plant Equipment936 M1.1 B927.3 M
Pretty Stable
Capital Lease Obligations29.1 M54.8 M23.1 M
Slightly volatile
Net Invested Capital3.9 B5.3 B2.9 B
Slightly volatile
Short and Long Term Debt284.7 M271.2 M209.5 M
Slightly volatile
Capital Stock96.6 M104.8 M76.5 M
Slightly volatile
Net Working Capital1.9 B2.8 B1 B
Slightly volatile
Property Plant And Equipment Gross1.7 B2.2 B1.1 B
Slightly volatile
Non Current Liabilities Other32 K36 K39.2 K
Slightly volatile

Windlas Biotech Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization159.7 M279.9 M158.5 M
Very volatile
Interest Expense22.3 M43.8 M41.4 M
Slightly volatile
Selling General Administrative30.2 M31.8 M244.6 M
Slightly volatile
Selling And Marketing Expenses125.9 M213.3 M66.6 M
Slightly volatile
Total Revenue5.2 B7.6 B4.2 B
Slightly volatile
Gross Profit1.6 B2.9 B1 B
Slightly volatile
Other Operating Expenses4.7 B6.9 B3.9 B
Slightly volatile
Operating Income478.8 M661.2 M345.9 M
Slightly volatile
EBIT585 M841.4 M417.1 M
Slightly volatile
Research Development59.4 M62.5 M39.3 M
Slightly volatile
EBITDA744.7 M1.1 B575.5 M
Slightly volatile
Cost Of Revenue3.6 B4.7 B3.2 B
Slightly volatile
Total Operating Expenses2.3 B2.2 B676.9 M
Slightly volatile
Income Before Tax552.3 M797.6 M371.9 M
Slightly volatile
Net Income Applicable To Common Shares319.3 M438 M234.7 M
Slightly volatile
Net Income422.1 M609.9 M267.2 M
Slightly volatile
Income Tax Expense130.8 M187.6 M105.5 M
Slightly volatile
Tax Provision135.9 M187.6 M124 M
Pretty Stable
Interest Income23.8 M15.4 M15.2 M
Slightly volatile
Net Income From Continuing Ops464.4 M609.9 M532.8 M
Slightly volatile
Reconciled Depreciation155.2 M279.9 M124.4 M
Slightly volatile

Windlas Biotech Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation159.7 M279.9 M158.5 M
Very volatile
Capital Expenditures318.3 M521.9 M277.4 M
Slightly volatile
Total Cash From Operating Activities456.4 M681.9 M365.5 M
Slightly volatile
Net Income488.8 M609.9 M301.7 M
Slightly volatile
End Period Cash Flow4 M4.2 M71.7 M
Slightly volatile
Begin Period Cash Flow72.7 M52.9 M80.3 M
Very volatile
Stock Based Compensation20.2 M24.6 M18.3 M
Pretty Stable
Dividends Paid96.4 M115 M80.4 M
Slightly volatile

Windlas Fundamental Market Drivers

Cash And Short Term Investments2.4 B

About Windlas Biotech Financial Statements

Windlas Biotech shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Windlas Biotech investors may analyze each financial statement separately, they are all interrelated. The changes in Windlas Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses on on Windlas Biotech's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue264.5 M277.8 M
Total Revenue7.6 B5.2 B
Cost Of Revenue4.7 B3.6 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
GMGeneral Motors
SSentinelOne
FFord Motor

Additional Tools for Windlas Stock Analysis

When running Windlas Biotech's price analysis, check to measure Windlas Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windlas Biotech is operating at the current time. Most of Windlas Biotech's value examination focuses on studying past and present price action to predict the probability of Windlas Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windlas Biotech's price. Additionally, you may evaluate how the addition of Windlas Biotech to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY